EndoRobotics Co., Ltd. is a South Korean startup founded in 2019 that has positioned itself as a leader in the development and commercialization of non-invasive endoscopic surgery robots and devices.
The company's slogan, "Endorobotics is a leader in the development and commercialization of non-invasive endoscopic surgery robots and devices." encapsulates its mission to bring together the realms of endoscopy and robotics for advanced therapeutic endoscopy.
With a focus on the Health Care and Robotics industries, EndoRobotics has garnered attention from investors, with its most recent Series B investment totaling a significant $8.30M. This investment was led by L&S Venture Capital, Partners Investment, Mirae Asset Capital, Pathfinder H, and Donghoon Investment, showcasing the company's appeal to a diverse array of valuable backers.
Based in South Korea, EndoRobotics epitomizes the innovative spirit of its home country and the potential for global influence in the field of medical robotics.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series B | $8.30M | 5 | 14 Aug 2023 | |
Grant | $300.00K | 1 | TIPS Program | 01 Jun 2022 |
Series A | $3.70M | 5 | Seoul Business Agency(SBA) | 25 Aug 2021 |
Seed Round | $1.00M | 1 | 24 Jun 2020 | |
Grant | $500.00K | 1 | TIPS Program | 01 May 2019 |
No recent news or press coverage available for EndoRobotics Co., Ltd..